Therefore, it is critical for clinicians to understand why patients with schizophrenia smoke in order to adapt treatment schemes. Understanding the reasons may also help to develop new drugs that target the nicotinic system in the brain as well as smoking cessation programs that are specifically designed for this particular patient population. RECENT FINDINGS: So far, several reasons have been identified which are believed to explain tobacco consumption in patients with schizophrenia. 